KEYNOTE-867: Phase 3, Randomized, Placebo-Controlled Study of Stereotactic Body Radiotherapy (SBRT) with or without Pembrolizumab in Patients with Unresected Stage I or II Non–Small-Cell Lung Cancer (NSCLC)
| Autor: | Jabbour, S.K., Houghton, B., Robinson, A.G., Quantin, X., Wehler, T., Kowalski, D., Ahn, M.J., Erman, M., Giaccone, G., Borghaei, H., McLean, J., Xu, Y., Souza, F., Pall, G. |
|---|---|
| Zdroj: | In International Journal of Radiation Oncology, Biology, Physics 1 November 2022 114(3) Supplement:e376-e377 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|